Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Cardiovascular Diseases 2 Metabolic Syndrome 1 Cardiotoxicity 1 Breast Diseases 1

Interventions

Anastrozole 8 exemestane 7 Trastuzumab 7 Letrozole 7 palbociclib 6 Docetaxel 6 abemaciclib 5 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 Cyclophosphamide 4 Tamoxifen 3 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Blood Pressure × Breast × Clear all

NCT05006196 2026-05-20

IMOGEN

Perspectum

Active not recruiting

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡